INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall Street tumbles as hot inflation data feeds worries about Fed rate hikes
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Oppenheimer Reiterates Outperform Rating on Inovio Pharmaceuticals (INO)
May 14, 2024 10:08 AM EDTOppenheimer analyst Hartaj Singh reiterated an Outperform rating and $40.00 price target on Inovio Pharmaceuticals (NASDAQ: INO)
The analyst comments "
Inovio Pharmaceuticals (INO) reported 1Q24 financial updates and business highlights on 05/13. The company continues on track to initiate the RRP confirmatory trial of... More



